Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Neurological Sciences
Erschienen in:

01.01.2018 | Editorial

News on the journal Neurological Sciences in 2017

verfasst von: Ilaria Di Donato, Antonio Federico

Erschienen in: Neurological Sciences | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Auszug

As usually, we report in this survey the main advances in neurology and neurosciences, as reported in the articles published in Neurological Sciences in the 2017 volume and related to all the main topics of neurology. …
Literatur
1.
Khoshnam SE, Winlow W, Farzaneh M, Farbood Y, Moghaddam HF (2017) Pathogenic mechanisms following ischemic stroke. Neurol Sci 38(7):1167–1186PubMedCrossRef
2.
Chen Z, Zheng J, Liu W, Yang K, Li K, Huang B, Zhu R, Lu X, Li L (2017a) The SG13S114 polymorphism of the ALOX5AP gene is associated with ischemic stroke in Europeans: a meta-analysis of 8062 subjects. Neurol Sci 38(4):579–587PubMedCrossRef
3.
4.
Türkanoğlu Özçelik A, Can Demirdöğen B, Demirkaya Ş, Adalı O (2017) Association of cytochrome P4502E1 and NAD(P)H:quinone oxidoreductase 1 genetic polymorphisms with susceptibility to large artery atherosclerotic ischemic stroke: a case-control study in the Turkish population. Neurol Sci 38(6):1077–1085PubMedCrossRef
5.
Formisano R, Azicnuda E, Sefid MK, Zampolini M, Scarponi F, Avesani R (2017) Early rehabilitation: benefits in patients with severe acquired brain injury. Neurol Sci 38(1):181–184PubMedCrossRef
6.
7.
Giannini N, Ulivi L, Maccarrone M, Montano V, Orlandi G, Ferrari E, Cravcenco C, Bonuccelli U, Mancuso M (2017) Epidemiology and cerebrovascular events related to cervical and intracranial arteries dissection: the experience of the city of Pisa. Neurol Sci 38(11):1985–1991PubMedCrossRef
8.
9.
Lee JS, Rhee HY, Yoon SS, Park KC (2017) Neurosyphilis combined with acute anterior thalamic infarction. Neurol Sci 38(11):2061–2063PubMedCrossRef
10.
Maali L, Khan S, Qeadan F, Ismail M, Ramaswamy D, Hedna VS (2017) Cerebral venous thrombosis: continental disparities. Neurol Sci 38(11):1963–1968PubMedCrossRef
11.
12.
13.
Tejada-Meza H, Modrego PJ (2017) Cerebellar vermis: a vulnerable location of remote brain haemorrhages after thrombolysis for ischaemic stroke. Neurol Sci 38(1):185–187PubMedCrossRef
14.
Paciaroni M, Pantoni L (2017) Thrombolysis in dementia patients with acute stroke: is it justified? Neurol Sci 38(1):27–31PubMedCrossRef
15.
Amato MP, Bertolotto A, Brunelli R, Cavalla P, Goretti B, Marrosu MG, Patti F, Pozzilli C, Provinciali L, Rizzo N, Strobelt N, Tedeschi G, Trojano M, Comi G (2017) Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. Neurol Sci. https://​doi.​org/​10.​1007/​s10072-017-3081-8
16.
Filippi M, Tedeschi G, Pantano P, De Stefano N, Zaratin P, Rocca MA, INNI Network (2017) The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS. Neurol Sci 38(6):1029–1038PubMedCrossRef
17.
18.
Laroni A, Brogi D, Brescia Morra V, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL (2017) Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy. Neurol Sci 38(1):53–59PubMedCrossRef
19.
Saccà F, Pane C, De Rosa A, Matarazzo M, Brescia Morra V (2017) Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection. Neurol Sci 38(3):501–502PubMedCrossRef
20.
21.
Maniscalco GT, Aponte R, Bruzzese D, Guarcello G, Manzo V, Napolitano M, Moreggia O, Chiariello F, Florio C (2017) THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study. Neurol Sci. https://​doi.​org/​10.​1007/​s10072-017-3148-6
22.
23.
Casanova B, Jarque I, Gascón F, Hernández-Boluda JC, Pérez-Miralles F, de la Rubia J, Alcalá C, Sanz J, Mallada J, Cervelló A, Navarré A, Carcelén-Gadea M, Boscá I, Gil-Perotin S, Solano C, Sanz MA, Coret F (2017) Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis. Neurol Sci 38(7):1213–1221PubMedPubMedCentralCrossRef
24.
25.
Terrin A, Barp A, Zanusso G, Gallo P, Cagnin A (2017) Sporadic Creutzfeldt-Jakob disease presenting with isolated progressive non-fluent aphasia in a young woman. Neurol Sci 38(8):1535–1537PubMedCrossRef
26.
Bonanni L, Cagnin A, Agosta F, Babiloni C, Borroni B, Bozzali M, Bruni AC, Filippi M, Galimberti D, Monastero R, Muscio C, Parnetti L, Perani D, Serra L, Silani V, Tiraboschi P, Padovani A, DLB-SINdem study group (2017) The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design. Neurol Sci 38(1):83–91PubMedCrossRef
27.
Kawada T (2017) Epidemiological information of dementia with Lewy bodies. Neurol Sci 38(8):1533–1534PubMedCrossRef
28.
Ryu DW, Kim JS, Lee JE, Park JW, Oh YS, An JY, Lee KS (2017) Association of arterial stiffness with cognition in patients with Lewy body disorder. Neurol Sci 38(7):1307–1313PubMedCrossRef
29.
Federico A, Tamburin S, Maier A, Faccini M, Casari R, Morbioli L, Lugoboni F (2017) Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study. Neurol Sci 38(1):137–142PubMedCrossRef
30.
31.
Basagni B, Luzzatti C, Navarrete E, Caputo M, Scrocco G, Damora A, Giunchi L, Gemignani P, Caiazzo A, Gambini MG, Avesani R, Mancuso M, Trojano L, De Tanti A (2017) VRT (verbal reasoning test): a new test for assessment of verbal reasoning. Test realization and Italian normative data from a multicentric study. Neurol Sci 38(4):643–650PubMedCrossRef
32.
Boccia M, Marin D, D’Antuono G, Ciurli P, Incoccia C, Antonucci G, Guariglia C, Piccardi L (2017) The Tower of London (ToL) in Italy: standardization of the ToL test in an Italian population. Neurol Sci 38(7):1263–1270PubMedCrossRef
33.
Catricalà E, Gobbi E, Battista P, Miozzo A, Polito C, Boschi V, Esposito V, Cuoco S, Barone P, Sorbi S, Cappa SF, Garrard P (2017) SAND: a Screening for Aphasia in NeuroDegeneration. Development and normative data. Neurol Sci 38(8):1469–1483PubMedCrossRef
34.
Cerciello M, Isella V, Proserpi A, Papagno C (2017) Assessment of free and cued recall in Alzheimer’s disease and vascular and frontotemporal dementia with 24-item Grober and Buschke test. Neurol Sci 38(1):115–122PubMedCrossRef
35.
Chipi E, Frattini G, Eusebi P, Mollica A, D’Andrea K, Russo M, Bernardelli A, Montanucci C, Luchetti E, Calabresi P, Parnetti L (2017) The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly. Neurol Sci. https://​doi.​org/​10.​1007/​s10072-017-3150-z
36.
Poletti B, Carelli L, Solca F, Lafronza A, Pedroli E, Faini A, Zago S, Ticozzi N, Ciammola A, Morelli C, Meriggi P, Cipresso P, Lulé D, Ludolph AC, Riva G, Silani V (2017) An eye-tracking controlled neuropsychological battery for cognitive assessment in neurological diseases. Neurol Sci 38(4):595–603PubMedCrossRef
37.
Giovagnoli AR, Manfredi V, Parente A, Schifano L, Oliveri S, Avanzini G (2017) Cognitive training in Alzheimer’s disease: a controlled randomized study. Neurol Sci 2017;38(8):1485–1493
38.
Xu B, Sui Y, Zhu C, Yang X, Zhou J, Li L, Ren L, Wang X (2017a) Music intervention on cognitive dysfunction in healthy older adults: a systematic review and meta-analysis. Neurol Sci 38(6):983–992PubMedCrossRef
39.
Ataç Uçar C, Gökçe Çokal B, Ünal Artık HA, İnan LE, Yoldaş TK (2017) Comparison of neutrophil-lymphocyte ratio (NLR) in Parkinson’s disease subtypes. Neurol Sci 38(2):287–293PubMedCrossRef
40.
Gökçe Çokal B, Yurtdaş M, Keskin Güler S, Güneş HN, Ataç Uçar C, Aytaç B, Durak ZE, Yoldaş TK, Durak İ, Çubukçu HC (2017) Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson’s disease. Neurol Sci 38(3):425–431PubMedCrossRef
41.
Hu X, Yang Y, Gong D (2017) Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson’s disease: a meta-analysis. Neurol Sci 38(3):407–414PubMedCrossRef
42.
Jiang S, Gao H, Luo Q, Wang P, Yang X (2017) The correlation of lymphocyte subsets, natural killer cell, and Parkinson’s disease: a meta-analysis. Neurol Sci 38(8):1373–1380PubMedCrossRef
43.
Ou R, Cao B, Wei Q, Hou Y, Xu Y, Song W, Zhao B, Shang H (2017) Serum uric acid levels and freezing of gait in Parkinson’s disease. Neurol Sci 38(6):955–960PubMedCrossRef
44.
45.
46.
Wang L, Hu W, Wang J, Fang F, Cheng G, Jiang Y, Xiao H, Wan Q (2017) Impact of serum uric acid, albumin and their interaction on Parkinson’s disease. Neurol Sci 38(2):331–336PubMedCrossRef
47.
Cova I, Di Battista ME, Vanacore N, Papi CP, Alampi G, Rubino A, Valente M, Meco G, Contri P, Di Pucchio A, Lacorte E, Priori A, Mariani C, Pomati S (2017) Adaptation and psychometric properties of the Italian version of the Non-Motor Symptoms Questionnaire for Parkinson’s disease. Neurol Sci 38(4):673–678PubMedCrossRef
48.
Toffoli M, Dreussi E, Cecchin E, Valente M, Sanvilli N, Montico M, Gagno S, Garziera M, Polano M, Savarese M, Calandra-Buonaura G, Placidi F, Terzaghi M, Toffoli G, Gigli GL (2017) SNCA 3'UTR genetic variants in patients with Parkinson’s disease and REM sleep behavior disorder. Neurol Sci 38(7):1233–1240PubMedCrossRef
49.
Zhang X, Sun X, Wang J, Tang L, Xie A (2017a) Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson’s disease: a meta and meta-regression analysis. Neurol Sci 38(1):163–170PubMedCrossRef
50.
51.
Balestrino R, Baroncini D, Fichera M, Donofrio CA, Franzin A, Mortini P, Comi G, Volontè MA (2017) Weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease is influenced by dyskinesias’ reduction and electrodes’ position. Neurol Sci 38(12):2123–2129PubMedCrossRef
52.
Forogh B, Rafiei M, Arbabi A, Motamed MR, Madani SP, Sajadi S (2017) Repeated sessions of transcranial direct current stimulation evaluation on fatigue and daytime sleepiness in Parkinson’s disease. Neurol Sci 38(2):249–254PubMedCrossRef
53.
54.
Cannas A, Meloni M, Mascia MM, Solla P, Cocco L, Muroni A, Floris G, Di Stefano F, Marrosu F (2017) Capgras syndrome in Parkinson's disease: two new cases and literature review. Neurol Sci 38(2):225–231ᅟ
55.
Santangelo G, Lagravinese G, Battini V, Chiorri C, Siciliano M, Abbruzzese G, Vitale C, Barone P (2017) The Parkinson’s Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals. Neurol Sci 38(5):845–853PubMedCrossRef
56.
57.
58.
Kim BC, Choi SM, Choi KH, Nam TS, Kim JT, Lee SH, Park MS, Yoon W (2017) MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson’s disease. Neurol Sci 38(4):627–633PubMedCrossRef
59.
60.
Ueda J, Yoshimura H, Shimizu K, Hino M, Kohara N (2017) Combined visual and semi-quantitative assessment of 123I-FP-CIT SPECT for the diagnosis of dopaminergic neurodegenerative diseases. Neurol Sci 38(7):1187–1191PubMedCrossRef
61.
Shaikh AG (2017) Tremor analysis separates Parkinson’s disease and dopamine receptor blockers induced parkinsonism. Neurol Sci 38(5):855–863PubMedCrossRef
62.
Taga A, Russo M, Manzoni GC, Torelli P (2017) The PACE study: lifetime and past-year prevalence of headache in Parma’s adult general population. Neurol Sci 38(5):789–795PubMedCrossRef
63.
Vladetić M, Jančuljak D, Butković Soldo S, Kralik K, Buljan K (2017) Health-related quality of life and ways of coping with stress in patients with migraine. Neurol Sci 38(2):295–301PubMedCrossRef
64.
Kurt ANC, Aydın A, Demir H, Erel Ö (2017) Headache in children and dynamic thiol/disulfide balance evaluation with a new method. Neurol Sci 38(8):1495–1499PubMedCrossRef
65.
Sangermani R, Boncimino A (2017) The use of nutraceutics in children’s and adolescent’s headache. Neurol Sci 38(Suppl 1):121–124PubMedCrossRef
66.
67.
68.
Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Bergandi F, Benedetto C (2017) Treating migraine with contraceptives. Neurol Sci 38(Suppl 1):85–89PubMedCrossRef
69.
70.
71.
Barbanti P, Aurilia C, Fofi L, Egeo G, Ferroni P (2017a) The role of anti-CGRP antibodies in the pathophysiology of primary headaches. Neurol Sci 38(Suppl 1):31–35PubMedCrossRef
72.
Manzoni GC, Russo M, Taga A, Torelli P (2017) Neurobiology of chronicization. Neurol Sci 38(Suppl 1):81–84PubMedCrossRef
73.
Paolucci M, Altamura C, Brunelli N, Rizzo AC, Assenza F, Pasqualetti P, Vernieri F (2017) Methylprednisolone plus diazepam i.v. as bridge therapy for medication overuse headache. Neurol Sci 38(11):2025–2029PubMedCrossRef
74.
75.
De Simone R, Ranieri A, Ferra G, Cautiero F (2017) Intravenous mannitol in status migrainosus treatment: a clinical case series. Neurol Sci 38(Suppl 1):163–167PubMedCrossRef
76.
Finocchi C, Sassos D (2017) Headache and arterial hypertension. Neurol Sci 38(Suppl 1):67–72PubMedCrossRef
77.
Ikeda K, Hanashiro S, Ishikawa Y, Sawada M, Kyuzen M, Morioka H, Ebina J, Nagasawa J, Yanagihashi M, Miura K, Hirayama T, Takazawa T, Kano O, Kawabe K, Iwasaki Y (2017) Treatment with telmisartan, a long-acting angiotensin II receptor blocker, prevents migraine attacks in Japanese non-responders to lomerizine. Neurol Sci 38(5):827–831PubMedCrossRef
78.
Santoro A, Fontana A, Miscio AM, Zarrelli MM, Copetti M, Leone MA (2017) Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting. Neurol Sci. https://​doi.​org/​10.​1007/​s10072-017-3054-y
79.
80.
Grazzi L (2017) Onabotulinumtoxin A for chronic migraine with medication overuse: clinical results of a long-term treatment. Neurol Sci 38(Suppl 1):141–143PubMedCrossRef
81.
Grazzi L, Egeo G, Liebler E, Padovan AM, Barbanti P (2017a) Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study. Neurol Sci 38(Suppl 1):197–199PubMedCrossRef
82.
Lovati C, Giani L (2017) Action mechanisms of Onabotulinum toxin-A: hints for selection of eligible patients. Neurol Sci 38(Suppl 1):131–140PubMedCrossRef
83.
Ünal-Artık HA, İnan LE, Ataç-Uçar C, Yoldaş TK (2017) Do bilateral and unilateral greater occipital nerve block effectiveness differ in chronic migraine patients? Neurol Sci 38(6):949–954PubMedCrossRef
84.
Di Fiore P, Bussone G, Galli A, Didier H, Peccarisi C, D’Amico D, Frediani F (2017) Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial. Neurol Sci 38(Suppl 1):201–206PubMedCrossRef
85.
Dahlke LA, Sable JJ, Andrasik F (2017) Behavioral therapy: emotion and pain, a common anatomical background. Neurol Sci 38(Suppl 1):157–161PubMedCrossRef
86.
Grazzi L, D’Amico D, Raggi A, Leonardi M, Ciusani E, Corsini E, D’Andrea G, Bolner A, Salgado-García F, Andrasik F, Sansone E (2017b) Mindfulness and pharmacological prophylaxis have comparable effect on biomarkers of inflammation and clinical indexes in chronic migraine with medication overuse: results at 12 months after withdrawal. Neurol Sci 38(Suppl 1):173–175PubMedCrossRef
87.
D’Onofrio F, Raimo S, Spitaleri D, Casucci G, Bussone G (2017) Usefulness of nutraceuticals in migraine prophylaxis. Neurol Sci 38(Suppl 1):117–120PubMedCrossRef
88.
Barbanti P, Fofi L, Aurilia C, Egeo G, Caprio M (2017b) Ketogenic diet in migraine: rationale, findings and perspectives. Neurol Sci 38(Suppl 1):111–115PubMedCrossRef
89.
Galli A, Di Fiore P, D’Arrigo G, Uggetti C, Squarza S, Leone M, D’Amico D, Frediani F (2017) Migraine with aura white matter lesions: preliminary data on clinical aspects. Neurol Sci 38(Suppl 1):7–10PubMedCrossRef
90.
Viticchi G, Falsetti L, Bartolini M, Buratti L, Pistelli L, Provinciali L, Silvestrini M (2017) Raven coloured progressive matrices in migraine without aura patients. Neurol Sci 38(Suppl 1):177–179PubMedCrossRef
91.
Uggetti C, Squarza S, Longaretti F, Galli A, Di Fiore P, Reganati PF, Campi A, Ardemagni A, Cariati M, Frediani F (2017) Migraine with aura and white matter lesions: an MRI study. Neurol Sci 38(Suppl 1):11–13PubMedCrossRef
92.
Gasparini S, Ferlazzo E, Ascoli M, Sueri C, Cianci V, Russo C, Pisani LR, Striano P, Elia M, Beghi E, Colica C, Aguglia U, Epilepsy Study Group of the Italian Neurological Society (2017) Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis. Neurol Sci 38(3):399–406PubMedCrossRef
93.
Jiménez-Arredondo RE, Brambila-Tapia AJ, Mercado-Silva FM, Ortiz-Aranda M, Benites-Godinez V, Olmos-García-de-Alba G, Figuera LE (2017) Association between brain structural anomalies, electroencephalogram and history of seizures in Mucopolysaccharidosis type II (Hunter syndrome). Neurol Sci 38(3):445–450PubMedCrossRef
94.
Keller R, Basta R, Salerno L, Elia M (2017) Autism, epilepsy, and synaptopathies: a not rare association. Neurol Sci 38(8):1353–1361PubMedCrossRef
95.
96.
Tuğcu B, Bitnel MK, Kaya FS, Güveli BT, Ataklı D (2017) Evaluation of inner retinal layers with optic coherence tomography in vigabatrin-exposed patients. Neurol Sci 38(8):1423–1427PubMedCrossRef
97.
Keppel Hesselink JM, Kopsky DJ (2017) Phenytoin: neuroprotection or neurotoxicity? Neurol Sci 38(6):1137–1141PubMedCrossRef
98.
Ferrari A, Renzetti P, Serrati C, Fancellu R (2017) Serial magnetic resonance study in super refractory status epilepticus: progressive involvement of striatum and pallidus is a possible predictive marker of negative outcome. Neurol Sci 38(8):1513–1516PubMedCrossRef
99.
Park D, Park JS (2017) Terminal latency abnormality in amyotrophic lateral sclerosis without split hand syndrome. Neurol Sci 38(5):775–781PubMedCrossRef
100.
Sako W, Abe T, Izumi Y, Yamazaki H, Matsui N, Harada M, Kaji R (2017) Spontaneous brain activity in the sensorimotor cortex in amyotrophic lateral sclerosis can be negatively regulated by corticospinal fiber integrity. Neurol Sci 38(5):755–760PubMedCrossRef
101.
Yamashita T, Hatakeyama T, Sato K, Fukui Y, Hishikawa N, Ohta Y, Nishiyama Y, Kawai N, Tamiya T, Abe K (2017) Flow-metabolism uncoupling in the cervical spinal cord of ALS patients. Neurol Sci 38(4):659–665PubMedCrossRef
102.
Forte G, Bocca B, Oggiano R, Clemente S, Asara Y, Sotgiu MA, Farace C, Montella A, Fois AG, Malaguarnera M, Pirina P, Madeddu R (2017) Essential trace elements in amyotrophic lateral sclerosis (ALS): results in a population of a risk area of Italy. Neurol Sci. https://​doi.​org/​10.​1007/​s10072-017-3018-2
103.
Siciliano M, Trojano L, Trojsi F, Greco R, Santoro M, Basile G, Piscopo F, D’Iorio A, Patrone M, Femiano C, Monsurrò M, Tedeschi G, Santangelo G (2017) Edinburgh Cognitive and Behavioural ALS Screen (ECAS)-Italian version: regression based norms and equivalent scores. Neurol Sci 38(6):1059–1068PubMedCrossRef
104.
Sato T, Natori T, Hata T, Yamashiro N, Shindo K, Takiyama Y (2017) Camptocormia as an onset symptom of myasthenia gravis. Neurol Sci 38(3):515–516PubMedCrossRef
105.
106.
Tao X, Wang W, Jing F, Wang Z, Chen Y, Wei D, Huang X (2017) Long-term efficacy and side effects of low-dose tacrolimus for the treatment of Myasthenia Gravis. Neurol Sci 38(2):325–330PubMedCrossRef
107.
de Pasqua S, Cavallieri F, D’Angelo R, Salvi F, Fini N, D’Alessandro R, Rinaldi R, Fasano A, Mandrioli J (2017) Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence? Neurol Sci 38(3):441–444PubMedCrossRef
108.
109.
de Paula EF, de Mello BL, de Carvalho DL, Della-Guardia B, de Almeida MD, Marins LV, Corrêa L (2017) Minor salivary gland biopsy for the diagnosis of familial amyloid polyneuropathy. Neurol Sci 38(2):311–318CrossRef
110.
Stancanelli C, Gentile L, Di Bella G, Minutoli F, Russo M, Vita G, Mazzeo A (2017) Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart. Neurol Sci 38(3):525–526PubMedCrossRef
111.
Nobile-Orazio E, Cocito D, Briani C, Plasmati R, Schenone A, Gallia F, Marjanovic I, Suffredini AL (2017) High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy. Neurol Sci 38(5):899–902PubMedCrossRef
112.
113.
Franciotta D, Gastaldi M, Benedetti L, Pesce G, Biagioli T, Lolli F, Costa G, Melis C, Andreetta F, Simoncini O, Giannotta C, Bazzigaluppi E, Fazio R, Bedin R, Ferraro D, Mariotto S, Ferrari S, Galloni E, De Riva V, Zardini E, Cortese A, Nobile-Orazio E (2017a) Diagnostics of dysimmune peripheral neuropathies. Neurol Sci 38(Suppl 2):243–247PubMedCrossRef
114.
Franciotta D, Gastaldi M, Benedetti L, Garnero M, Biagioli T, Brogi M, Costa G, Fadda E, Andreetta F, Simoncini O, Giannotta C, Bazzigaluppi E, Fazio R, Bedin R, Ferraro D, Mariotto S, Ferrari S, Galloni E, De Riva V, Zardini E, Cortese A, Nobile-Orazio E (2017b) Diagnostics of anti-MAG antibody polyneuropathy. Neurol Sci 38(Suppl 2):249–252PubMedCrossRef
115.
116.
Baldin E, Testoni S, de Pasqua S, Ferro S, Albani F, Baruzzi A, D’Alessandro R, PERNO study group (2017) Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy. Neurol Sci 38(2):255–262PubMedCrossRef
117.
Xue L, Wang Y, Yue S, Zhang J (2017) The expression of miRNA-221 and miRNA-222 in gliomas patients and their prognosis. Neurol Sci 38(1):67–73PubMedCrossRef
118.
Tang Y, Zhao S, Wang J, Li D, Ren Q, Tang Y (2017) Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma. Neurol Sci 38(6):1087–1092PubMedCrossRef
119.
Prasad M, Kathuria P, Nair P, Kumar A, Prasad K (2017) Mobile phone use and risk of brain tumours: a systematic review of association between study quality, source of funding, and research outcomes. Neurol Sci 38(5):797–810PubMedCrossRef
120.
Tini P, Nardone V, Pastina P, Battaglia G, Vinciguerra C, Carfagno T, Rubino G, Carbone SF, Sebaste L, Cerase A, Federico A, Pirtoli L (2017) Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS). Neurol Sci 38(6):975–982PubMedCrossRef
121.
Yuliang W, Yuan W, Xuezhen W, He M, Qi Z, Jinbo C (2017) A novel SPAST frameshift mutation in a Chinese family with hereditary spastic paraplegia. Neurol Sci 38(2):365–367PubMedCrossRef
122.
Zhao G, Liu X, Jiang P (2017) Identification of a novel SPG4 tandem base substitution in a Chinese hereditary spastic paraplegia family. Neurol Sci 38(5):903–905PubMedCrossRef
123.
Africa L, Margollicci M, Salvatore S, Shalbafan B, Peruzzi L, Togha M, Sorrentino V, Federico A (2017) Compound heterozygosity in the GALC gene in a late onset Iranian patient with spastic paraparesis, peripheral neuropathy and leukoencephalopathy. Neurol Sci. https://​doi.​org/​10.​1007/​s10072-017-2986-6
124.
Carluccio MA, Di Donato I, Pescini F, Battaglini M, Bianchi S, Valenti R, Nannucci S, Franci B, Stromillo ML, De Stefano N, Inzitari D, Pantoni L, Nuti R, Federico A, Gonnelli S, Dotti MT (2017) Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neurol Sci 38(7):1333–1336PubMedCrossRef
125.
126.
Da Pozzo P, Cardaioli E, Rubegni A, Gallus GN, Malandrini A, Rufa A, Battisti C, Carluccio MA, Rocchi R, Giannini F, Bianchi A, Mancuso M, Siciliano G, Dotti MT, Federico A (2017) Novel POLG mutations and variable clinical phenotypes in 13 Italian patients. Neurol Sci 38(4):563–570PubMedCrossRef
127.
128.
129.
130.
Ueno T, Nishizawa H, Suzuki C, Nunomura JI, Tomiyama M (2017) Downbeat nystagmus as an initial clinical sign in spinocerebellar ataxia type 6. Neurol Sci 38(8):1543–1545PubMedCrossRef
131.
132.
Yucesan E, Ugur Iseri SA, Bilgic B, Gormez Z, Bakir Gungor B, Sarac A, Ozdemir O, Sagiroglu M, Gurvit H, Hanagasi H, Ozbek U (2017) SYNE1 related cerebellar ataxia presents with variable phenotypes in a consanguineous family from Turkey. Neurol Sci. https://​doi.​org/​10.​1007/​s10072-017-3049-8
133.
Zádori D, Szpisjak L, Madar L, Varga VE, Csányi B, Bencsik K, Balogh I, Harangi M, Kereszty É, Vécsei L, Klivényi P (2017) Different phenotypes in identical twins with cerebrotendinous xanthomatosis: case series. Neurol Sci 38(3):481–483PubMedCrossRef
134.
Zhang SY, Hu Q, Tang T, Liu C, Li CC, Yang XG, Zang YY, Cai WX (2017b) Role of CACNA1C gene polymorphisms and protein expressions in the pathogenesis of schizophrenia: a case-control study in a Chinese population. Neurol Sci 38(8):1393–1403PubMedCrossRef
135.
Buratti L, Luconi MP, Viticchi G, Provinciali L, Silvestrini M (2017) Vitamin D supplementation: a useful strategy for restless legs syndrome exacerbation in a patient with Turner syndrome. Neurol Sci 38(6):1135–1136PubMedCrossRef
136.
Leonardi L, Aceto MG, Marcotulli C, Arcuria G, Serrao M, Pierelli F, Paone P, Filla A, Roca A, Casali C (2017) A wearable proprioceptive stabilizer for rehabilitation of limb and gait ataxia in hereditary cerebellar ataxias: a pilot open-labeled study. Neurol Sci 38(3):459–463PubMedCrossRef
137.
Megías-Vericat JE, García-Robles A, Company-Albir MJ, Fernández-Megía MJ, Pérez-Miralles FC, López-Briz E, Casanova B, Poveda JL (2017) Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases. Neurol Sci 38(5):727–743PubMedCrossRef
Metadaten
Titel
News on the journal Neurological Sciences in 2017
verfasst von
Ilaria Di Donato
Antonio Federico
Publikationsdatum
01.01.2018
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 1/2018
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-017-3241-x

Weitere Artikel der Ausgabe 1/2018

Resection of melanocytic nevi as a potential treatment of anti-NMDAR encephalitis patients without tumor: report of three cases

  • Brief Communication

Correction to: Peripheral markers of autophagy in polyglutamine diseases

  • Correction

The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly

  • Original Article

Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis

  • Review Article

Right-to-left shunt may be prone to affect the white matter integrity of posterior circulation in migraine without aura

  • Original Article

3-Hz postural tremor in multiple system atrophy cerebellar type (MSA-C)—a static posturography study

  • Original Article

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Ehe schützt nicht vor Demenz

  • 25.04.2025
  • Demenz
  • Nachrichten

Eigentlich leben Verheiratete länger und gesünder. Eine aktuelle Untersuchung kommt jedoch zu dem überraschenden Schluss, dass sie eher an Demenz erkranken als nie Verheiratete, Geschiedene oder Verwitwete.

Lohnt sich die Karotis-Revaskularisation?

Die medikamentöse Therapie für Menschen mit Karotisstenosen hat sich in den vergangenen Dekaden verbessert. Braucht es also noch einen invasiven Eingriff zur Revaskularisation der Halsschlagader bei geringem bis moderatem Risiko für einen ipsilateralen Schlaganfall?

Neuartige Antikörpertherapie bremst MS über zwei Jahre hinweg

Eine Therapie mit dem C40-Ligand-Blocker Frexalimab kann MS-Schübe und neue MRT-Läsionen über zwei Jahre hinweg verhindern. Dafür spricht die Auswertung einer offen fortgeführten Phase-2-Studie.

Therapiestopp bei älteren MS-Kranken kann sich lohnen

Eine Analyse aus Kanada bestätigt: Setzen ältere MS-Kranke die Behandlung mit Basistherapeutika ab, müssen sie kaum mit neuen Schüben und MRT-Auffälligkeiten rechnen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise